Macular Disease Foundation Australia (MDFA) is pleased with the Federal Government’s increased investment to make primary health care more affordable and accessible for Australians doing it tough due to the current cost of living crisis. We fully support increasing bulk-billing incentives in general practice and the positive cost-saving outcomes.
We recently welcomed the Federal Government’s decision to defer the private health insurance reclassification of intravitreal (eye) injections from 1 July 2025 to 1 July 2026 and undertake further consultation. This must be an opportunity to address the overall affordability of sight saving injections, particularly for financially vulnerable Australians in need of this treatment.
As people with neovascular age-related macular degeneration require frequent and ongoing eye injections, MDFA will continue to make recommendations to the Government about ways to increase access to affordable eye injection treatment, including incentivising ophthalmologists to bulk bill Australian pension card holders who require sight-saving treatment.
Posted: 26 March 2025
Government defers MBS private health insurance reclassification
Macular Disease Foundation Australia (MDFA) has welcomed the Federal Government’s decision to defer the private health insurance reclassification of intravitreal (eye) injections from 1 July 2025 to 1 July 2026 and undertake further consultation.
